Scientists test a ‘bispecific’ antibody that helps T cells zero in on treatment-resistant cancers

Category: Oncology & Cancer

Summary: Although immunotherapy has achieved increasing prominence in the panoply of innovative cancer treatments, it remains an imperfect tool—too many tumors simply do not respond.

Source: Immunology news

Read More

Be the first to comment

Leave a Reply

Your email address will not be published.